Notice Title

Consent to the Distribution of New Medicines

Publication Date
9 Nov 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go5169
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Sublocade Modified Release Injection
Active Ingredient: Buprenorphine 100mg
Dosage Form: Injection (depot)
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Albany Molecular Research Inc (AMRI), Vermont, United States of America
   
Product: Sublocade Modified Release Injection
Active Ingredient: Buprenorphine 300mg
Dosage Form: Injection (depot)
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Albany Molecular Research Inc (AMRI), Vermont, United States of America


Dated this 3rd day of November 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).